Inventor · disambiguated record
Philippe Gabant
Also filed as: GABANT PHILIPPE
17 granted patents·11 pending applications·214 citations·filing 1993–2024
93Inventor score
Top patents by PatentIndex Score
28 records- 0194US11427800B2Controlled growth of microorganismsSYNGULON SA·Filed 2018·Granted Aug 30, 2022·4 cites·18 claims
- 0294US9333227B2Controlled growth of microorganismsSYNGULON SA·Filed 2014·Granted May 10, 2016·18 cites·17 claims
- 0393US11492651B2Methods and compositions for making bacteriocins and antimicrobial peptidesSYNGULON SA·Filed 2018·Granted Nov 8, 2022·4 cites·16 claims
- 0493US10188114B2Controlled growth of microorganismsSYNGULON SA·Filed 2016·Granted Jan 29, 2019·8 cites·28 claims
- 0591US7176029B2Cloning and/or sequencing vectorUNIV BRUXELLES·Filed 2004·Granted Feb 13, 2007·33 cites·18 claims
- 0686US5910438ACloning and/or sequencing vectorUNIV BRUXELLES·Filed 1993·Granted Jun 8, 1999·80 cites·14 claims
- 0785US8877504B2Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to toxic moleculeUNIV BRUXELLES·Filed 2013·Granted Nov 4, 2014·5 cites·6 claims
- 0885US2025122550A1Methods and compositions for making bacteriocins and antimicrobial peptidesSYNGULON SA·Filed 2024·Application pending·0 cites
- 0983US12297422B2Controlled growth of microorganismsSYNGULON SA·Filed 2022·Granted May 13, 2025·0 cites·31 claims
- 1083US6180407B1Cloning and/or sequencing vectorUNIV BRUXELLES·Filed 1999·Granted Jan 30, 2001·45 cites·14 claims
- 1181US12195780B2Methods and compositions for making bacteriocins and antimicrobial peptidesSYNGULON SA·Filed 2022·Granted Jan 14, 2025·0 cites·10 claims
- 1277US2025290112A1Engineering antimicrobial peptidesSYNGULON SA·Filed 2024·Application pending·0 cites
- 1376US8470580B2Method for the selection of recombination clones comprising a sequence encoding an antidote protein to a toxic moleculeGABANT PHILIPPE·Filed 2002·Granted Jun 25, 2013·8 cites·17 claims
- 1472US8318497B2Reversible, parallel and multitask cloning method and kitSZPIRER CEDRIC·Filed 2003·Granted Nov 27, 2012·7 cites·31 claims
- 1571US11932672B2Fermentation processSYNGULON S A·Filed 2018·Granted Mar 19, 2024·2 cites·17 claims
- 1661US2023416797A1Modulating antimicrobial peptide half-lifeSYNGULON SA·Filed 2021·Application pending·0 cites
- 1760US12173343B2Engineering antimicrobial peptidesSYNGULON SA·Filed 2019·Granted Dec 24, 2024·0 cites·15 claims
- 1859US2008299661A1Cloning and/or sequencing vectorBERNARD PHILIPPE·Filed 2007·Application pending·0 cites
- 1958US2023414707A1Control of microorganisms in microbial communitiesSYNGULON SA·Filed 2021·Application pending·0 cites
- 2057US2025346639A1Bacteriocin polypeptides, nucleic acids encoding same, and methods of use thereofSYNGULON SA·Filed 2023·Application pending·0 cites
- 2157US2024197820A1Bacteriocin for new applicationSYNGULON S A·Filed 2022·Application pending·0 cites
- 2257US2024285726A1Bacteriocin for new applicationSYNGULON S A·Filed 2022·Application pending·0 cites
- 2342US2003017600A1Double selection vectorFiled 2000·Application pending·0 cites
- 2441US2005260585A1Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organismsSZPIRER CEDRIC·Filed 2003·Application pending·0 cites
- 2540US7022892B1Non-human genetically modified mammal lacking the alpha-fetoproteinUNIV BRUXELLES·Filed 2000·Granted Apr 4, 2006·0 cites·3 claims
- 2638US2006234278A1Sequences used to identify if a female mammal comprises a mutation in the alpha-fetoprotein sequence(S) or a partial or total deletion of the alpha-fetoprotein sequence(S)GABANT PHILIPPE·Filed 2006·Application pending·0 cites
- 2733US9309518B2Reversible, parallel and multitask cloning method and kitSZPIRER CÉDRIC·Filed 2012·Granted Apr 12, 2016·0 cites·12 claims
- 2826US7910298B2Method for a (high through-put) screening detection of genetic modifications in genome engineeringIMMUNEHEALTH·Filed 2005·Granted Mar 22, 2011·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Philippe Gabant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →